CLSI EP25-A
Evaluation of Stability of In Vitro Diagnostic Reagents; Approved Guideline, EP25Astandard by Clinical and Laboratory Standards Institute, 09/01/2009
CLSI M11-A8
Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria; Approved Standard - Eighth Edition, M11A8Estandard by Clinical and Laboratory Standards Institute, 02/01/2012
CLSI C56-A
Hemolysis, Icterus, and Lipemia/Turbidity Indices as Indicators of Interference in Clinical Laboratory Analysis; Approved Guideline, C56AEstandard by Clinical and Laboratory Standards Institute, 07/01/2012
CLSI M35-A2 (R2018)
Abbreviated Identification of Bacteria and Yeast; Approved Guideline - Second Edition, M35A2standard by Clinical and Laboratory Standards Institute, 11/01/2008
CLSI I/LA29-A
Detection of HLA-Specific Alloantibody by Flow Cytometry and Solid Phase Assays, Proposed Guideline, ILA29AEstandard by Clinical and Laboratory Standards Institute, 01/01/2008
CLSI H42-A2 (R2018)
Enumeration of Immunologically Defined Cell Populations by Flow Cytometry; Approved Guideline, Second Edition, H42-A2standard by Clinical and Laboratory Standards Institute, 05/01/2007
CLSI C40-A2
Analytical Procedures for the Determination of Lead in Blood and Urine; Approved Guideline, C40A2Estandard by Clinical and Laboratory Standards Institute, 10/01/2013
CLSI M44-A2
Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts, 3rd Edition, M44Ed3Estandard by Clinical and Laboratory Standards Institute, 12/10/2018
CLSI EP23-A (R2018)
Laboratory Quality Control Based on Risk Management; Approved Guideline, EP23AEstandard by Clinical and Laboratory Standards Institute, 10/01/2011
CLSI GP16-A3 (R2018)
Urinalysis; Approved Guideline--Third Edition, GP16A3standard by Clinical and Laboratory Standards Institute, 02/01/2009